Healthcare
More news about this topic
-
CommentaryParabilis now the largest VC-backed biotech IPO
June 10, 2026The stock jumped 58% in its first day of trading on the Nasdaq Global Select Market on Wednesday.Article
Learn more » -
Pharma Biotools QuarterlyPharma Biotools VC Trends
June 3, 2026The Q1 2026 Pharma Biotools VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.Research
Learn more » -
Venture CapitalSome investors are turning to biotech as a hedge against potential AI bubbles
May 29, 2026They’re betting that with the continuous need for health care, the sector is more immune.Article
Learn more » -
Medtech QuarterlyMedtech VC and PE Trends
May 13, 2026The Q1 2026 Medtech VC and PE Trends report provides an analysis of recent VC and PE activity and includes a market map of leading VC- and PE-backed companies in the space.Research
Learn more » -
HealthcareElder care is rare bright spot in tough Q1 for healthcare services
May 7, 2026Deal value fell more than 23% YoY as buyers became more discriminating.Article
Learn more » -
Healthcare Services ReportHealthcare Services Report
May 7, 2026The Q1 2026 Healthcare Services Report provides in-depth analysis of industry trends and evolving PE investment strategies, including deals data and maps of key PE-backed companies and investors.Research
Learn more » -
Healthtech QuarterlyHealthtech VC Trends
April 30, 2026The Q1 2026 Healthtech VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.Research
Learn more » -
AIPitchBook Analyst Note: AI Will Deliver Care to Billions and Break the System That Built It
April 29, 202681% of US physicians now use AI. We map a five-layer AI care delivery stack, profile dozens of companies, and project healthcare cost scenarios.Research
Learn more » -
Biopharma QuarterlyBiopharma VC Trends
April 28, 2026Biopharma VC deal value fell to $7.2 billion in Q1 2026 as capital shifted toward exits. We examine modality trends, oncology, and obesity deal flow, and what a strengthening exit environment means for 2026.Research
Learn more » -
Leveraged LoansEurope’s leveraged loan borrowers shrink 2028 maturity wall, but challenges loom
April 28, 2026A sizeable portion of debt remains from the buyout boom of 2021.Article
Learn more » -
Medtech Public Comp Sheet and Valuation GuideMedtech Public Comp Sheet and Valuation Guide
April 24, 2026Our Medtech Public Comp Sheet and Valuation Guide tracks stock performances, valuations, and market caps of key publicly traded medtech companies.Research
Learn more » -
Healthtech Public Comp Sheet and Valuation GuideHealthtech Public Comp Sheet and Valuation Guide
April 15, 2026Our Healthtech Public Comp Sheet and Valuation Guide tracks stock performances, valuations, and market caps of key publicly traded healthtech companies.Research
Learn more » -
BiopharmaJeito holds $1.2B close for biopharma fund as industry braces for next patent cliff
April 8, 2026Investors are eyeing a strong M&A cycle ahead of 2030.Article
Learn more » -
Healthcare Funds ReportHealthcare Funds Report
April 2, 2026The H2 2025 Healthcare Funds Report offers a comprehensive guide to healthcare and life sciences specialist managers across both private equity and venture capital.Research
Learn more » -
HealthtechLinda Yaccarino’s GLP-1 telehealth unicorn raises $200M on adherence claim that bucks industry norm
March 26, 2026EMed secures Series A at a $2B valuation. But will its adherence rate hold up at scale?Article
Learn more » -
Pharma Services QuarterlyPharma Services Report
March 11, 2026The Q4 2025 Pharma Services Report provides in-depth analysis of industry trends and evolving PE investment strategies, including deals data and maps of key PE-backed companies and investors.Research
Learn more » -
Analyst NoteHealthcare IT PE Update
March 10, 2026The H2 2025 Healthcare IT PE Update highlights recent PE deal activity and dominant trends in healthcare IT.Research
Learn more » -
Healthtech QuarterlyHealthtech VC Trends
February 25, 2026The Q4 2025 Healthtech VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.Research
Learn more »